suPAR overexpression leads to increased atherosclerotic and necrotic plaques in a murine model of atherosclerosis. WT (n = 18) and suPARTg (n = 21) mice were maintained on a low-fat diet until 3 months of age and were then transfected with Pcsk9-AAV and fed a western diet (WD) for 10 weeks. At this point, aortic roots were obtained, paraffin embedded, and stained with H&E and Mac2 (galectin 3). (A) Cross sections of aortic roots from C57BL/6 WT and suPARTg mice show total lesion area, outlined in dashed lin
December 16, 2022
New Immune Target to Treat Cardiovascular Disease Discovered
December 16, 2022 —  For the longest time, clinicians have treated cardiovascular disease by focusing on diabetes and…
Read More
From left, Craig Schumacher, Jake and Yvette Honda-Schumacher. Image courtesy of Cedars-Sinai
December 16, 2022
A Heart Fix That Fits
December 16, 2022 —  Yvette Honda-Schumacher was 20 weeks pregnant and had just had a routine anatomy ultrasound when…
Read More
Innovative approach can deliver high-fidelity cardiopulmonary exercise test results comparable to gold-standard testing with a wearable sensor during routine daily activities
December 15, 2022
physIQ’s eVO2Max Demonstrates Breakout Ability to Estimate Cardiopulmonary Functional Capacity from Wearable Sensor Data During Daily Routine Activity
December 15, 2022 — physIQ announced a novel approach to estimating maximum oxygen utilization (VO2Max) using wearable…
Read More
Doctors from the Emory Heart & Vascular Center are joining forces with the Family Heart Foundation, a leading research and advocacy organization, to find and more widely treat undiagnosed patients living with a common genetic condition that causes very high levels of unhealthy cholesterol, heightening the risk for heart attacks and strokes even at a young age.
December 15, 2022
Emory Doctors and Family Heart Foundation Team Up to Help Patients with Dangerously High Cholesterol Caused by Genetic Condition
December 15, 2022 —  Doctors from the Emory Heart & Vascular Center are joining forces with the Family Heart…
Read More
From left, Qian Ma, PhD, and Yuqing Huo, MD, PhD. Photo courtesy of Michael Holahan, Augusta University
December 15, 2022
New Target in the Fight Against Heart Disease
December 15, 2022 —  Soon after cholesterol and fat start depositing on the lining of the blood vessels that supply…
Read More
Edwards Lifesciences identified the top data releases from 2022 that contributed most to shaping awareness about the extent and impact of underdiagnosis and undertreatment of aortic stenosis (AS).
December 14, 2022
Edwards Identifies Top Data Releases of 2022 that Highlight the Impacts of Aortic Stenosis Undertreatment
December 14, 2022 — Edwards Lifesciences identified the top data releases from 2022 that contributed most to shaping…
Read More
Edwards Lifesciences identified the top data releases from 2022 that contributed most to shaping awareness about the extent and impact of underdiagnosis and undertreatment of aortic stenosis (AS).
December 14, 2022
Preventing Millions of Strokes and Heart Attacks Doesn’t Have to Come with the Risk of Life-threatening Bleeding
December 14, 2022 — Verseon announced that the European Journal of Medicinal Chemistry has published a paper describing…
Read More
Verseon’s scientific journey to highly promising therapeutic candidates for cardiovascular disease appears in European Journal of Medicinal Chemistry
December 14, 2022
Field Medical and CardioNXT Collaborate to Deliver Novel Integration of Focal Pulsed Field Ablation And 3D Mapping & Navigation For Treatment of Cardiac Arrhythmias
December 14, 2022 —  Field Medical, Inc. and CardioNXT, Inc. announce a strategic collaboration to provide the first-of…
Read More
Corindus, A Siemens Healthineers Company, has officially rebranded as Siemens Healthineers
December 14, 2022
Corindus, A Siemens Healthineers Company, Is Now Siemens Healthineers Endovascular Robotics
December 14, 2022 — Corindus, A Siemens Healthineers Company, has been rebranded to Siemens Healthineers Endovascular…
Read More
Series to feature leading experts discussing the current and future trends in the carotid treatment market
December 13, 2022
InspireMD Announces “12 Days of Carotid Stenting” Video Series Featuring Fireside Chats with Top Multidisciplinary Vascular Specialists
December 13, 2022 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention…
Read More
Edwards Lifesciences Corporation announced that one-year results on patients treated in the single-arm, prospective, global, multi-center TRISCEND study of the company's EVOQUE transcatheter tricuspid valve replacement system demonstrated favorable safety, efficacy and quality-of-life outcomes.
December 13, 2022
Edwards Announces One-year Data on Transfemoral Transcatheter Tricuspid Valve Replacement
December 13, 2022 — Edwards Lifesciences Corporation announced that one-year results on patients treated in the single-…
Read More
Image courtesy of Intermountain Healthcare
December 13, 2022
Study Finds Patients Without Standard Modifiable Heart Risk Factors Are Common and More Likely to Fare Better After Heart Attack Than Patients with Known Factors
December 13, 2022 — A new study by researchers at Intermountain Healthcare in Salt Lake City finds that patients…
Read More
The global pacemakers market is set to grow at a compound annual growth rate (CAGR) of 5.4% between 2022 and 2025, driven by increasing population at a risk of cardiovascular diseases.
December 12, 2022
Global Pacemakers Market Set to Grow at 5.4% CAGR Over Next 3 Years
December 12, 2022 —  The global pacemakers market is set to grow at a compound annual growth rate (CAGR) of 5.4%…
Read More
Michael A. Mussallem
December 12, 2022
Edwards Lifesciences Announces CEO Succession Plan
December 12, 2022 —  Edwards Lifesciences Corporation announced that following regular succession planning discussions…
Read More
US-based Weill Cornell Medicine has initiated a new clinical project together with the Mwanza International Trials Unit located in the Lake Zone of Tanzania with the aim of exploring the burden of arrhythmia in adults with and without HIV.
December 12, 2022
Weill Cornell Medicine partners with Poland-based company Cardiomatics to investigate the relationship between HIV and heart rhythm disorders
December 12, 2022 —  US-based Weill Cornell Medicine has initiated a new clinical project together with the Mwanza…
Read More
Clinical abstract focuses on value of PURE EP’s and its groundbreaking High Frequency Algorithm (HFA) during pulmonary vein isolation
December 09, 2022
BioSig’s PURE EP System Highlighted in the Journal of Atrial Fibrillation and Electrophysiology
December 9, 2022 —    BioSig Technologies, Inc.  an advanced digital signal processing technology company delivering…
Read More
Dr. Rami Kahwash, director of Ohio State’s Heart and Vascular Research Organization and a professor of clinical medicine in the Ohio State College of Medicine.
December 09, 2022
Ohio State First in World to Participate in Trial Confirming Efficacy of Novel Heart Failure Treatment
December 9, 2022 —  The Ohio State University Wexner Medical Center is first in the world to randomize a patient in a…
Read More
December 09, 2022
Ninerafaxstat Showcased at the 19th Annual Global Cardio Vascular Clinical Trialists (CVCT) Forum with Focus on the Potential in Non-obstructive Hypertrophic Cardiomyopathy
December 9, 2022 —  Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies…
Read More
Cardiac care should follow the patient on a virtual journey and deliver high-fidelity insights to care providers, eliminating the gaps in data transmission
December 08, 2022
With Minutes Between Life and Death, Continuous Remote ECG Monitoring Saves Lives
December 8, 2022 — Heart disease is the number one killer in the U.S., and high-fidelity monitoring is the beginning of…
Read More
Along with physician leaders and members, the society has helped the subspecialty officially join NRMP’s Medical Specialties Matching Program in 2025
December 08, 2022
SCAI Leads the Way for Interventional Cardiology to Join “The Match”
December 8, 2022 — The Society for Cardiovascular Angiography & Interventions (SCAI), a leading nonprofit medical…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now